Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
168 Third Avenue, Waltham, MA, USA, 02451
Compare
Compare
Traded in other countries / regions
TMO.Argentina
•
TMOF.Austria
•
TMOS34.Brazil
•
TN8.Germany
•
TMO.Mexico
•
TMO.Peru
•
TFS.Switzerland
•
0R0H.UK
•
TMO.USA
Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | 2.51 | |||||
| Interest Coverage | 16.98 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.44 | |||||
| Beneish M-Score | -2.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.1 | |||||
| 3-Year EBITDA Growth Rate | 25.5 | |||||
| 3-Year EPS without NRI Growth Rate | 39 | |||||
| 3-Year FCF Growth Rate | 22.4 | |||||
| 3-Year Book Growth Rate | 14.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 6.83 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 7.28 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.16 | |||||
| 9-Day RSI | 67.2 | |||||
| 14-Day RSI | 64.14 | |||||
| 6-1 Month Momentum % | -2.09 | |||||
| 12-1 Month Momentum % | -2.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.65 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 82.2 | |||||
| Days Sales Outstanding | 59.06 | |||||
| Days Payable | 39.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.19 | |||||
| Dividend Payout Ratio | 0.06 | |||||
| 3-Year Dividend Growth Rate | 15.2 | |||||
| Forward Dividend Yield % | 0.2 | |||||
| 5-Year Yield-on-Cost % | 0.34 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.63 | |||||
| Operating Margin % | 22.72 | |||||
| Net Margin % | 17.37 | |||||
| ROE % | 18.63 | |||||
| ROA % | 8.86 | |||||
| ROIC % | 12.06 | |||||
| ROC (Joel Greenblatt) % | 74.12 | |||||
| ROCE % | 12.31 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.82 | |||||
| Forward PE Ratio | 26.2 | |||||
| PE Ratio without NRI | 31.82 | |||||
| Shiller PE Ratio | 60.39 | |||||
| Price-to-Owner-Earnings | 35.47 | |||||
| PEG Ratio | 1.35 | |||||
| PS Ratio | 5.53 | |||||
| PB Ratio | 5.54 | |||||
| Price-to-Free-Cash-Flow | 37.38 | |||||
| Price-to-Operating-Cash-Flow | 26.8 | |||||
| EV-to-EBIT | 28.96 | |||||
| EV-to-Forward-EBIT | 24.72 | |||||
| EV-to-EBITDA | 21.75 | |||||
| EV-to-Forward-EBITDA | 22.31 | |||||
| EV-to-Revenue | 6.14 | |||||
| EV-to-Forward-Revenue | 6.12 | |||||
| EV-to-FCF | 41.71 | |||||
| Price-to-Projected-FCF | 2.23 | |||||
| Price-to-DCF (Earnings Based) | 0.84 | |||||
| Price-to-DCF (FCF Based) | 1.28 | |||||
| Price-to-Median-PS-Value | 1.48 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.28 | |||||
| Earnings Yield (Greenblatt) % | 3.45 | |||||
| Forward Rate of Return (Yacktman) % | 22.16 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:TMO
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 42,820 | ||
| EPS (TTM) ($) | 18.79 | ||
| Beta | 0.7 | ||
| Volatility % | 25.55 | ||
| 14-Day RSI | 64.14 | ||
| 14-Day ATR ($) | 12.569072 | ||
| 20-Day SMA ($) | 584.8615 | ||
| 12-1 Month Momentum % | -2.81 | ||
| 52-Week Range ($) | 497.83 - 672.34 | ||
| Shares Outstanding (Mil) | 391.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thermo Fisher Scientific Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||